• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Rimtuzalcap

CAS No. 2167246-24-2

Rimtuzalcap ( CAD-1883 )

产品货号. M28737 CAS No. 2167246-24-2

Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥599 有现货
5MG ¥988 有现货
10MG ¥1596 有现货
25MG ¥3151 有现货
50MG ¥4690 有现货
100MG ¥6707 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Rimtuzalcap
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。
  • 产品描述
    Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA).(In Vitro):Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.(In Vivo):Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
  • 体外实验
    Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.
  • 体内实验
    Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
  • 同义词
    CAD-1883
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    Potassium Channel
  • 受体
    human glucagon receptor
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2167246-24-2
  • 分子量
    378.428
  • 分子式
    C18H24F2N6O
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 250 mg/mL (660.64 mM)
  • SMILES
    Cc1ccn(n1)-c1nc(NC2CCC(F)(F)CC2)cc(n1)N1CCOCC1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.M A Cascieri, et al. Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor. J Biol Chem. 1999 Mar 26;274(13):8694-7.
产品手册
关联产品
  • JNJ 303

    JNJ 303 是一种有效的 IK 阻断剂 (IC50 : 64 nM)。

  • AVE-0118

    AVE-0118 是一种有效的 I(to)/I(Kur) 阻滞剂、Kv1.5 通道抑制剂,IC50 为 5.6 uM。

  • Quinidine hydrochlor...

    奎宁的光学异构体,从金鸡纳树和类似植物的树皮中提取。